VENICE Study Nevirapine Full Dose/Dose Escalation

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

July 31, 2008

Study Completion Date

February 28, 2009

Conditions
HIV Infections
Interventions
DRUG

nevirapine

Full-dose nevirapine from baseline (200 mg bid).

DRUG

nevirapine

Nevirapine with an increase in the initial dose (200 mg once daily for 14 days and 200 mg bid thereafter)

Trial Locations (15)

14004

Hospital Provincial Reina Sofía de Córdoba, Córdoba

28006

Hospital de la Princesa, Madrid

28007

Hospital Gregorio Marañón, Madrid

28034

Hospital Ramón y Cajal, Madrid

28046

Hospital La Paz, Madrid

28880

Hospital Príncipe de Asturias, Alcalá de Henares

29010

Hospital Virgen de la Victoria, Málaga

Unknown

Hospital General Alicante, Alicante

Hospital General de Elche, Elche

Hospital Germanas Trias i Pujol, Badalona

Hospital Clinic, Barcelona

Hospital Vall d´Hebrón, Barcelona

08003

Hospital del Mar, Barcelona

08025

Hospital Santa Creu y Sant Pau, Barcelona

08400

Hospital General de Granollers, Granollers

All Listed Sponsors
lead

Clinical Trial Agency of HIV Study Group

OTHER

NCT00704249 - VENICE Study Nevirapine Full Dose/Dose Escalation | Biotech Hunter | Biotech Hunter